Bifidobacterium Lactobacillus M8

N/A

Report date: 2024/01/11 14:13:00

Base Information

Drug NameBifidobacterium Lactobacillus M8
Drug Alias NameM8
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Acne VulgarisKidney Failure, Chronic +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesWeihai Municipal HospitalBeijing Tiantan Hospital, Capital Medical University
China Registration ClassN/A

Develop Information

Active CompaniesWeihai Municipal HospitalBeijing Tiantan Hospital, Capital Medical University
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Acne VulgarisKidney Failure, Chronic +[7] 
Inactive IndicationsAsthmaPelvic NeoplasmsColorectal Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A